Vertex spars with UK's May over Orkambi pricing

Vertex is reaching high in its attempt to get U.K. reimbursement for its cystic fibrosis medications by writing to request "urgent intervention" from Prime Minister Theresa May, citing it as "a test case for the Government’s delivery of accelerated access to innovative medicines in the U.K."